Literature DB >> 26989729

Recurrent pregnancy loss in a subject with heterozygote factor V Leiden mutation; a case report.

Reza Ebrahimzadeh-Vesal1, Roza Azam1, Arvin Ghazarian1, Mogge Hajesmaeili2, Najmeh Ranji3, Mohammad Reza Ezzati4, Mehrdad Sadri4, Mohammad Ali Mohammadi4, Siamak Khavandi4.   

Abstract

Recurrent pregnancy loss is usually defined as the loss of two or more consecutive pregnancies before 20 weeks of gestation, which occurs in approximately 5% of reproductive-aged women. It has been suggested that women with thrombophilia have an increased risk of pregnancy loss and other adverse pregnancy outcomes. Thrombophilia is an important predisposition to blood clot formation and is considered as a significant risk factor for recurrent pregnancy loss. The inherited predisposition to thrombophilia is most often associated with factor V Leiden mutation, prothrombin G20210A mutation, and methylenetetrahydrofolate reductase C677T and A1298C gene variants. The net effect is an increased cleavage of prothrombin to thrombin and excessive blood coagulation.

Entities:  

Keywords:  Factor V Leiden mutation; Hereditary thrombophilia; Recurrent pregnancy loss

Year:  2014        PMID: 26989729      PMCID: PMC4757054     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  24 in total

Review 1.  Advances in understanding pathogenic mechanisms of thrombophilic disorders.

Authors:  Björn Dahlbäck
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].

Authors:  Mislav Herman; Josip Djelmis; Zeljko Troselj; Marina Ivanisević
Journal:  Acta Med Croatica       Date:  2006-06

Review 4.  An overview of genetic risk factors in thrombophilia.

Authors:  Valentina Djordjević; Ljiljana Rakićević; Dragica Radojković
Journal:  Srp Arh Celok Lek       Date:  2010-01       Impact factor: 0.207

5.  Mutations in coagulation factors in women with unexplained late fetal loss.

Authors:  I Martinelli; E Taioli; I Cetin; A Marinoni; S Gerosa; M V Villa; M Bozzo; P M Mannucci
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

Review 6.  The role of factor V Leiden in maternal health and the outcome of pregnancy.

Authors:  C J Calderwood; I A Greer
Journal:  Curr Drug Targets       Date:  2005-08       Impact factor: 3.465

7.  Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

Authors:  Willem M Lijfering; Jan-Leendert P Brouwer; Nic J G M Veeger; Ivan Bank; Michiel Coppens; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

8.  The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.

Authors:  Reya Gohil; George Peck; Pankaj Sharma
Journal:  Thromb Haemost       Date:  2009-08       Impact factor: 5.249

9.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Authors:  F R Rosendaal; T Koster; J P Vandenbroucke; P H Reitsma
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

Review 10.  Factor V Leiden thrombophilia.

Authors:  Jody Lynn Kujovich
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.